U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Subchronic schizophrenia

MedGen UID:
124356
•Concept ID:
C0270381
•
Mental or Behavioral Dysfunction
Synonym: Subchronic Schizophrenia
SNOMED CT: Subchronic schizophrenia (16990005)

Professional guidelines

PubMed

Modelling prefrontal cortex deficits in schizophrenia: implications for treatment.
Pratt JA, Winchester C, Egerton A, Cochran SM, Morris BJ
Br J Pharmacol 2008 Mar;153 Suppl 1(Suppl 1):S465-70. doi: 10.1038/bjp.2008.24. PMID: 18311160Free PMC Article
Management of the negative symptoms of schizophrenia: new treatment options.
Möller HJ
CNS Drugs 2003;17(11):793-823. doi: 10.2165/00023210-200317110-00003. PMID: 12921492
Phasic and process psychoses: a polydiagnostic comparison among the Frankfurt Classification System, DSM III, RDC, Feighner criteria and ICD-9.
Gerbaldo H, Demisch L, Bochnik HJ
Psychopathology 1989;22(1):14-27. doi: 10.1159/000284575. PMID: 2727226

Recent clinical studies

Etiology

A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia.
Hirsch SR, Kissling W, Bäuml J, Power A, O'Connor R
J Clin Psychiatry 2002 Jun;63(6):516-23. doi: 10.4088/jcp.v63n0609. PMID: 12088164
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.
Colonna L, Saleem P, Dondey-Nouvel L, Rein W
Int Clin Psychopharmacol 2000 Jan;15(1):13-22. doi: 10.1097/00004850-200015010-00002. PMID: 10836281
A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia.
King DJ, Link CG, Kowalcyk B
Psychopharmacology (Berl) 1998 May;137(2):139-46. doi: 10.1007/s002130050603. PMID: 9630000
Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG
Arch Gen Psychiatry 1997 Jun;54(6):549-57. doi: 10.1001/archpsyc.1997.01830180067009. PMID: 9193196
ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia.
Fabre LF Jr, Arvanitis L, Pultz J, Jones VM, Malick JB, Slotnick VB
Clin Ther 1995 May-Jun;17(3):366-78. doi: 10.1016/0149-2918(95)80102-2. PMID: 7585841

Diagnosis

A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia.
Hirsch SR, Kissling W, Bäuml J, Power A, O'Connor R
J Clin Psychiatry 2002 Jun;63(6):516-23. doi: 10.4088/jcp.v63n0609. PMID: 12088164
Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG
Arch Gen Psychiatry 1997 Jun;54(6):549-57. doi: 10.1001/archpsyc.1997.01830180067009. PMID: 9193196
ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia.
Fabre LF Jr, Arvanitis L, Pultz J, Jones VM, Malick JB, Slotnick VB
Clin Ther 1995 May-Jun;17(3):366-78. doi: 10.1016/0149-2918(95)80102-2. PMID: 7585841
Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.
Santos JL, Cabranes JA, Vazquez C, Fuentenebro F, Almoguera I, Ramos JA
Biol Psychiatry 1989 Aug;26(4):381-8. doi: 10.1016/0006-3223(89)90054-1. PMID: 2669981

Therapy

Spotlight on ziprasidone in schizophrenia and schizoaffective disorder.
Gunasekara NS, Spencer CM, Keating GM
CNS Drugs 2002;16(9):645-52. doi: 10.2165/00023210-200216090-00005. PMID: 12153335
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
Gunasekara NS, Spencer CM, Keating GM
Drugs 2002;62(8):1217-51. doi: 10.2165/00003495-200262080-00015. PMID: 12010089
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.
Colonna L, Saleem P, Dondey-Nouvel L, Rein W
Int Clin Psychopharmacol 2000 Jan;15(1):13-22. doi: 10.1097/00004850-200015010-00002. PMID: 10836281
Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG
Arch Gen Psychiatry 1997 Jun;54(6):549-57. doi: 10.1001/archpsyc.1997.01830180067009. PMID: 9193196
ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia.
Fabre LF Jr, Arvanitis L, Pultz J, Jones VM, Malick JB, Slotnick VB
Clin Ther 1995 May-Jun;17(3):366-78. doi: 10.1016/0149-2918(95)80102-2. PMID: 7585841

Prognosis

Spotlight on ziprasidone in schizophrenia and schizoaffective disorder.
Gunasekara NS, Spencer CM, Keating GM
CNS Drugs 2002;16(9):645-52. doi: 10.2165/00023210-200216090-00005. PMID: 12153335
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
Gunasekara NS, Spencer CM, Keating GM
Drugs 2002;62(8):1217-51. doi: 10.2165/00003495-200262080-00015. PMID: 12010089
A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia.
King DJ, Link CG, Kowalcyk B
Psychopharmacology (Berl) 1998 May;137(2):139-46. doi: 10.1007/s002130050603. PMID: 9630000
ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group.
Borison RL, Arvanitis LA, Miller BG
J Clin Psychopharmacol 1996 Apr;16(2):158-69. doi: 10.1097/00004714-199604000-00008. PMID: 8690831

Clinical prediction guides

Spotlight on ziprasidone in schizophrenia and schizoaffective disorder.
Gunasekara NS, Spencer CM, Keating GM
CNS Drugs 2002;16(9):645-52. doi: 10.2165/00023210-200216090-00005. PMID: 12153335
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
Gunasekara NS, Spencer CM, Keating GM
Drugs 2002;62(8):1217-51. doi: 10.2165/00003495-200262080-00015. PMID: 12010089
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.
Colonna L, Saleem P, Dondey-Nouvel L, Rein W
Int Clin Psychopharmacol 2000 Jan;15(1):13-22. doi: 10.1097/00004850-200015010-00002. PMID: 10836281
ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia.
Fabre LF Jr, Arvanitis L, Pultz J, Jones VM, Malick JB, Slotnick VB
Clin Ther 1995 May-Jun;17(3):366-78. doi: 10.1016/0149-2918(95)80102-2. PMID: 7585841
Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.
Santos JL, Cabranes JA, Vazquez C, Fuentenebro F, Almoguera I, Ramos JA
Biol Psychiatry 1989 Aug;26(4):381-8. doi: 10.1016/0006-3223(89)90054-1. PMID: 2669981

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...